摘要 |
The invention concerns cyclopeptides of formula (I): Cyclo-(Arg-Gly-Asp-X-Y) in which X is Cha, Nal, Phe, 2-R<1>-Phe, 3-R<1>-Phe, 4-R<1>-Phe, homo-Phe, Phg, Thi, Trp, Tyr or derivatives of Tyr, whereby the OH group can be etherified by alkyl groups containing 1-18 C-atoms and the amino-acid groups given can also be derivatives, R<1> is NH2, NO2, I, Br, Cl, F, alkyl with 1-18 C-atoms, Ar, Ar-O or <3>H, Y is Gly in which the alpha N-atom may be substituted by R<2> and/or the alpha C-atom may be substituted by R<3> and/or R<4>, with the provision that Gly has at least one of the substituents specified, Ar is phenyl which may be substituted by one or two of the groups NH2, NO2, I, Br, Cl, F, alkyl with 1-6 C-atoms or <3>H, R<2>, R<3> or R<4>, independently of each other, are alkyl with 1-18 C-atoms or R<2> and R<3> or R<3> and R<4> together in each case are a branched or unbranched alkylene chain with 3 to 18 C-atoms so that either the alpha N-atom and the alpha C-atom together with the alkylene chain, or the alpha C-atom alone, forms a ring with the alkylene chain, whereby, when optically active amino-acid or amino-acid-derivative groups are involved, both the D- and the L-form are included, plus derivatives, in particular the beta -ester of aspartic acid or N-guanidine acyl derivatives of arginine or prodrug as well as their physiologically acceptable salts. These compounds act as integrin inhibitors and may be used particularly for the prophylaxis and treatment of circulatory and angiogenic conditions and microbial infections as well as in tumor therapy.
|
申请人 |
MERCK PATENT GMBH, 64293 DARMSTADT, DE |
发明人 |
JONCZYK, ALFRED, DR., 64295 DARMSTADT, DE;GOODMAN, SIMON L., DR., 64286 DARMSTADT, DE;DIEFENBACH, BEATE, DR., 64289 DARMSTADT, DE;KESSLER, HORST, PROF., 85748 GARCHING, DE;KOPPITZ, MARCUS, DR., 85748 GARCHING, DE |